Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma‐glutamyl transpeptidase levels
暂无分享,去创建一个
Henry Völzke | Matthias Nauck | Marcus Dörr | H. Völzke | S. Baumeister | R. Haring | H. Wallaschofski | M. Nauck | M. Dörr | Henri Wallaschofski | Robin Haring | Sebastian E. Baumeister
[1] A. Ogawa,et al. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. , 2009, Atherosclerosis.
[2] U. John,et al. Extended recruitment efforts minimize attrition but not necessarily bias. , 2009, Journal of clinical epidemiology.
[3] Jochen Klenk,et al. Longitudinal Change in Serum Gamma-Glutamyltransferase and Cardiovascular Disease Mortality: A Prospective Population-Based Study in 76 113 Austrian Adults , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[4] David W. Hosmer,et al. Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .
[5] Georg Endler,et al. C-reactive protein and all-cause mortality in a large hospital-based cohort. , 2008, Clinical chemistry.
[6] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[7] Matthias Egger,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.
[8] G. Targher,et al. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. , 2007, Atherosclerosis.
[9] Thomas Kohlmann,et al. Menopausal status and hepatic steatosis in a general female population , 2007, Gut.
[10] R. D'Agostino,et al. Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[11] M. Charles,et al. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort , 2006, Diabetologia.
[12] Jeanne M Clark,et al. The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults , 2006, Journal of clinical gastroenterology.
[13] P. Giral,et al. Letter regarding article by Ruttmann et al, "gamma-Glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults". , 2006, Circulation.
[14] B. Neuschwander‐Tetri. Nonalcoholic steatohepatitis and the metabolic syndrome. , 2005, The American journal of the medical sciences.
[15] H. Concin,et al. γ-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults , 2005, Circulation.
[16] U. John,et al. Risk factors for goiter in a previously iodine-deficient region. , 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[17] James G Wright,et al. The development of a comorbidity index with physical function as the outcome. , 2005, Journal of clinical epidemiology.
[18] U. John,et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. , 2005, World journal of gastroenterology.
[19] Henry Völzke,et al. The association of thyroid function with cardiac mass and left ventricular hypertrophy. , 2005, The Journal of clinical endocrinology and metabolism.
[20] D. Jacobs,et al. Association between serum gamma-glutamyltransferase and C-reactive protein. , 2005, Atherosclerosis.
[21] U. John,et al. Study of Health in Pomerania (SHIP): A health examination survey in an east German region: Objectives and design , 2005, Sozial- und Präventivmedizin.
[22] D. Jacobs,et al. γ-Glutamyltransferase, Obesity, and the Risk of Type 2 Diabetes: Observational Cohort Study among 20,158 Middle-Aged Men and Women , 2004 .
[23] D. Jacobs,et al. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? , 2004, Free radical biology & medicine.
[24] J. Horton,et al. Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.
[25] K. Tatara,et al. Serum γ-Glutamyltransferase and Risk of Metabolic Syndrome and Type 2 Diabetes in Middle-Aged Japanese Men , 2004 .
[26] U. John,et al. Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the Study of Health in Pomerania (SHIP). , 2004, Alcoholism, clinical and experimental research.
[27] D. Jacobs,et al. ReviewIs Serum Gamma Glutamyltransferase a Marker of Oxidative Stress? , 2004, Free radical research.
[28] C. Mottin,et al. The Role of Ultrasound in the Diagnosis of Hepatic Steatosis in Morbidly Obese Patients , 2004, Obesity surgery.
[29] U. John,et al. Thyroid function and carotid wall thickness. , 2004, The Journal of clinical endocrinology and metabolism.
[30] K. Tatara,et al. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. , 2004, Diabetes care.
[31] C. Lewis,et al. γ-Glutamyltransferase Is a Predictor of Incident Diabetes and Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2003 .
[32] C. Lewis,et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. , 2003, Clinical chemistry.
[33] P. Elwood,et al. γ-Glutamyltransferase and risk of stroke: the EUROSTROKE project , 2002, Journal of epidemiology and community health.
[34] C. Tiribelli,et al. The spectrum of liver disease in the general population: lesson from the Dionysos study. , 2001, Journal of hepatology.
[35] François Gueyffier,et al. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials , 2001, BMJ : British Medical Journal.
[36] A. Rantala,et al. Gamma‐glutamyl transpeptidase and the metabolic syndrome , 2000, Journal of internal medicine.
[37] P. Jousilahti,et al. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. , 2000, Stroke.
[38] U. John,et al. Methoden zur Qualitätssicherung im medizinischen Untersuchungsbereich epidemiologischer Feldstudien : Die Study of Health in Pomerania (SHIP) , 2000 .
[39] G. Brandi,et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.
[40] U. John,et al. [Methods for quality assurance of medical examination in epidemiological field studies: the "Study of Health in Pomerania" (SHIP)]. , 2000, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).
[41] I. Kawachi,et al. The relationship of income inequality to mortality: does the choice of indicator matter? , 1997, Social science & medicine.
[42] H. Brenner,et al. Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. , 1997, Preventive medicine.
[43] S. Ebrahim,et al. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. , 1995, American journal of epidemiology.
[44] K. Miura,et al. Serum gamma-glutamyl transferase level in predicting hypertension among male drinkers. , 1994, Journal of human hypertension.
[45] O. Nilssen,et al. Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø Study. , 1994, American journal of epidemiology.
[46] M. Dolgin,et al. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels , 1994 .
[47] J. Seidell,et al. Fat distribution and gamma-glutamyl transferase in relation to serum lipids and blood pressure in 38-year old Dutch males. , 1989, European Journal of Clinical Nutrition.
[48] T. Whitehead,et al. Effect of Body Mass and other Factors on Serum Liver Enzyme Levels in Men Attending for Well Population Screening , 1989, Annals of clinical biochemistry.
[49] R. M. Harvey,et al. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels , 1973 .
[50] H. Blackburn,et al. Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.